Why AddLife stock moves
AddLife moved slightly lower on an ordinary day for the stock.
Written after the close on ·
Why today
16,304 news analyzed todayAddLife moved slightly lower on an ordinary day for the stock.
The market fell clearly over the same day, so AddLife held up better than OMX Stockholm 30, the main Swedish index.
Over the last five trading days, AddLife rose slightly while the market was roughly flat.
The most recent company news is a disclosure that Swedbank Robur, a fund manager, raised its stake in AddLife, but it came out before the session opened, so it does not explain the move.
The share price is still well below its late-October high, and trading was thinner than usual.
Today's move of −0.59% was 0.6 times a normal day's 1.0%. OMX Stockholm 30 moved −1.01% on the same day.
AddLife −0.59%OMX Stockholm 30 −1.01%In step with the market
What analysts expect, and how often they have been right
Analysts’ estimates for AddLife.
AddLife earned more than expected in 2 out of 8 reports.
Not in the chart because no estimate and result are available: 1 of the 9 reports in this period, the latest on February 5, 2025.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 5 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 184.10 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedSEK
Next reported quarter: expected earnings per share of 1.34 SEK (February 3). For the current fiscal year, expected earnings per share changed from 6.28 SEK three months ago to 6.36 SEK now. 2026 estimate: 6.36 SEK. 2027 estimate: 7.75 SEK. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. August 27: Buy about 82 thousand SEK. August 27: Buy about 5 thousand SEK. August 26: Buy about 4 thousand SEK. June 9: Buy about 131 thousand SEK. June 3: Buy about 142 thousand SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +16% and earnings per share +123%.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 22.4 bn SEKRevenue 2025: 10.4 bn SEK
What the key figures say about AddLife
The figures connect what AddLife earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 1.56 SEK–4.59 SEK. Peers: BONESUPPORT 4.08 SEK, DENTSPLY SIRONA -$0.61, Dynavox Group 2.58 SEK. 2026 estimate: 6.36 SEK (4.85 SEK–7.85 SEK). 2027 estimate: 7.75 SEK (6.29 SEK–9.17 SEK).
What the company sold during the year.
2022–2025: 9.1 bn SEK–10.4 bn SEK. Peers: BONESUPPORT 1.4 bn SEK, DENTSPLY SIRONA $3.6B, Dynavox Group 2.6 bn SEK. 2026 estimate: 11.0 bn SEK (11.0 bn SEK–11.0 bn SEK). 2027 estimate: 12.0 bn SEK (11.8 bn SEK–12.2 bn SEK).
The percentage of revenue left after the costs of running the business.
2022–2025: 4.5%–7.9%. Peers: BONESUPPORT 26.2%, DENTSPLY SIRONA 5.1%, Dynavox Group 14.7%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 3.8%–10.3%. Peers: BONESUPPORT 29.7%, DENTSPLY SIRONA −8.6%, Dynavox Group 40.4%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 27.5–70.1. Peers: BONESUPPORT 78.6, Dynavox Group 27.4. 2026 estimate: 28.9. 2027 estimate: 23.7.
What investors pay for each unit the company sells.
2022–2025: 1.38–1.86. Peers: BONESUPPORT 14.89, DENTSPLY SIRONA 0.53, Dynavox Group 2.87. 2026 estimate: 2.04. 2027 estimate: 1.88.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 0.00 SEK–2.00 SEK.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 0.0%–1.8%. Peers: BONESUPPORT 0.0%, DENTSPLY SIRONA 0.0%, Dynavox Group 0.7%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 2.22–3.63. Peers: BONESUPPORT -1.39, DENTSPLY SIRONA 4.17, Dynavox Group 1.58.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 2.66–3.56. Peers: BONESUPPORT 21.07, DENTSPLY SIRONA 1.38, Dynavox Group 9.19.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 24.0–30.5.
Cash left after investments, divided by the number of shares.
2022–2025: 3.82 SEK–9.09 SEK. Peers: BONESUPPORT 5.05 SEK, DENTSPLY SIRONA $0.72, Dynavox Group 2.18 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 38.0%–42.8%.
The dividend explained
A dividend is money paid to shareholders. AddLife paid 1.50 SEK per share in the twelve months through November 6, 2026.
On the ex-dividend day, May 7, 2026, AddLife traded without the right to the 1.50 SEK dividend. The price went from 145.90 SEK to 142.70 SEK; including the dividend, the day's change was −1.2%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2017: 0.36 SEK2018: 0.52 SEK2019: 0.55 SEK2020: 0.50 SEK2021: 1.50 SEK2022: 2.00 SEK2023: 0.00 SEK2024: 0.50 SEK2025: 0.75 SEK2026 so far: 1.50 SEK
What to watch next, and why
The earnings report shows how AddLife's revenue and profit have changed.
- Earnings report
The earnings report shows how AddLife's revenue and profit have changed.
Add to calendar
More about AddLife
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Fredrik Dalborg, CEOBuyabout 82 thousand SEK
- Märta Isoz Dalborg, CEO (closely associated)Buyabout 5 thousand SEK
- Vera Isoz Dalborg, CEO (closely associated)Buyabout 4 thousand SEK
- Eva Maria Cecilia Sandell Elmstedt, board memberBuyabout 131 thousand SEK
- Fredrik Dalborg, CEOBuyabout 142 thousand SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days AddLife usually moved about 6.2%. On a normal day it moves 1.0%.
+2.92% Why? +0.90% −0.59% +15.11%
10,000 SEK in AddLife bought on November 7, 2016 is worth 57,900 SEK today, with dividends reinvested.
What would 10,000 SEK in AddLife be worth today? →
What would 10,000 SEK in AddLife be worth today?
57,900 SEK
with dividends reinvested, bought on November 7, 2016.
The five biggest days of the journey
· −26.3% · the whole market fell 1.0% the same day · report day
· −20.8% · the whole market fell 0.6% the same day · report day
· −17.9% · the whole market fell 0.1% the same day · report day
· +16.7% · the whole market rose 3.5% the same day · report day
· +15.5% · the whole market fell 0.4% the same day · report day
Earlier days
+0.99% market −0.11% AddLife rose slightly over the trading days this week, while the broader Stockholm market was roughly flat. Read →
AddLife rose slightly over the trading days this week, while the broader Stockholm market was roughly flat.
The company bought MoonSurge, a Portuguese distributor of surgical equipment with about 5 million euros in yearly sales, on Tuesday 3 November.
Swedbank Robur increased its holding to about 5.05% of shares on Thursday 5 November, which may have added some buying interest.
Trading was well below its usual level, so the move was small and ordinary in size.
+0.38% market −0.32% AddLife barely moved, as the market slipped slightly. Read →
AddLife barely moved, as the market slipped slightly.
Over the last five trading days, AddLife rose slightly, a bit more than the OMX Stockholm 30, which also rose slightly.
Swedbank Robur raised its holding in AddLife to just over 5 percent, a disclosed share purchase.
That purchase is the one new company item from the last session, and it is an ordinary-sized move.
+2.39% market +0.83% AddLife rose, more than the market, which rose clearly. Read →
AddLife rose, more than the market, which rose clearly.
No company news from the last session explains the move.
Over the last five trading days AddLife rose slightly, in line with the market.
The MoonSurge acquisition came out before the session, so it was known when trading opened and is at most background.
Volume was about four times normal, so heavy trading was part of the move.
−1.03% market +3.01% AddLife fell slightly over the week's trading days while the OMX Stockholm 30 rose clearly, so it moved against the market. Read →
AddLife fell slightly over the week's trading days while the OMX Stockholm 30 rose clearly, so it moved against the market.
The move was ordinary in size, and trading was thin.
The Healthcare peers rose modestly over the same days.
Next, the company reports again on Wednesday 3 February 2027.
+1.94% market +0.41% AddLife rose clearly, moving apart from the market. Read →
AddLife rose clearly, moving apart from the market.
Its rise followed analyst price target raises after the quarterly report, though those came before the session opened.
The company's earnings call highlighted strong organic growth and better margins.
Over the last five trading days, AddLife rose slightly while the OMX Stockholm 30 fell sharply.
Its trading volume was around its usual level.
+1.49% market −3.67% AddLife rose slightly over the last five trading days, moving against a clearly falling Stockholm market. Read →
AddLife rose slightly over the last five trading days, moving against a clearly falling Stockholm market.
The rise came after the Q3 report earlier this week, which showed higher profit and cash flow but earnings that missed expectations.
Analysts reacted mixed: DNB Carnegie cut its rating to hold, while Nordea, ABG and SB1 raised their price targets, the fair value they see for the shares.
Next, watch the company's next report on 3 February 2027.
−5.19% market −2.51% AddLife fell far more than the Stockholm market. Read →
AddLife fell far more than the Stockholm market.
The move was very big for AddLife, and trading was heavy.
Over the last five trading days, AddLife rose clearly while the market fell.
Its latest quarter missed expectations, so profit disappointed analysts, which likely weighed on the shares.
Next, watch the ABG and Nordea target-price updates and the Lehnen acquisition closing.
+2.92% market +0.17% AddLife rose very sharply, while the broader Stockholm market was roughly flat. Read →
AddLife rose very sharply, while the broader Stockholm market was roughly flat.
Its latest quarterly report came out that day, and profit beat forecasts, with stronger margins and faster acquisitions.
Over the last five trading days, the stock rose strongly while the OMX Stockholm 30 fell slightly.
A move this large is rare for AddLife, and trading volume was well above normal.
The stock still sits below its highest close of the past year.
+1.93% market −0.89% AddLife rose, with company news reinforcing the move, at odds with a weaker market. Read →
AddLife rose, with company news reinforcing the move, at odds with a weaker market.
AddLife rose clearly in the last session while the OMX Stockholm 30 fell clearly, so the move was company-specific.
SB1 Markets kept its buy rating and raised its price target, the share price it sees as fair, to SEK 212 from SEK 208.
Analysts likely saw more upside after the earlier share price rise.
Trading was heavy, about twice a normal session, which points to strong interest.
+3.18% market +1.25% AddLife rose sharply, moving well ahead of a market that also edged higher. Read →
AddLife rose sharply, moving well ahead of a market that also edged higher.
The best-supported reason is news that came out during the session: the Q3 consensus, meaning the average of analyst estimates, expects adjusted EBITA (operating profit before some items) of about SEK 297m.
That estimate was published when trading had already moved, so it may partly explain the jump.
Over the last five trading days the stock rose strongly, which is a big move for AddLife, and trading volume was far above normal, so heavy buying likely added to the rise.
Earlier this week, AddLife agreed to buy the German accessibility-bathroom maker LEHNEN, with about €5m in sales, which likely added to sentiment.
+7.40% market +1.19% AddLife rose sharply over the last five trading days, clearly more than the broader Stockholm market, which edged up. Read →
AddLife rose sharply over the last five trading days, clearly more than the broader Stockholm market, which edged up.
Investors may also have been positioning ahead of the adjusted EBITA (earnings before interest, taxes and amortisation, adjusted for one-off items) result expected on 21 October 2026, where consensus expects about SEK 297 million.
Next to watch are that quarterly report and how the market reacts to it.
+0.51% market −0.62% AddLife rose slightly, moving against a slightly weaker OMX Stockholm 30 without any clearly new company news that day. Read →
AddLife rose slightly, moving against a slightly weaker OMX Stockholm 30 without any clearly new company news that day.
The acquisition of Germany's LEHNEN GmbH, a family-owned maker of accessible bathroom and medical-aid products with about 5 million euro in sales, was announced earlier in the week, so it was already known before the session opened and is unlikely to be the direct trigger.
The slight gain was most likely a continuation of the sharp rise over the five days, with investors still digesting the deal and the company's growing exposure to healthcare equipment.
Watch the upcoming earnings report on 21 October 2026 for any update on how the acquisition fits into AddLife's Medtech division.
+1.16% market −0.02% AddLife rose clearly, with the market roughly flat. Read →
AddLife rose clearly, with the market roughly flat.
The likeliest reason is the acquisition of the German accessible-bathroom maker LEHNEN, announced the day before the session, which adds a company with about 5 million euros in sales and roughly 30 staff to its Medtech business area.
Over the last five trading days the stock also rose clearly while the OMX Stockholm 30 edged up slightly, so the company moved more than the market.
Investors often read such bolt-on acquisitions as a sign of growth, which partly explains the reaction.
The next thing to watch is the earnings report on 21 October 2026.
+2.37% market +0.21% AddLife rose sharply on its German bathroom-solutions acquisition. Read →
AddLife rose sharply on its German bathroom-solutions acquisition.
AddLife, listed on Nasdaq Stockholm, rose slightly over the last five trading days while the Stockholm market was roughly flat, with the sharp gain coming in the latest session.
The deal is small, so it likely lifted sentiment more than earnings, and the broader market gave no clear push either way.
Watch the earnings report due next week for a fuller picture.
Learn more · Why do stocks go up and down?